Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Ulipristal Acetate in Renal Impairment
NCT02634437Phase 1Completed
- Sponsor
- Allergan
- Start
- Dec 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ulipristal in Uterine Fibroids (UF) (3 arms), sponsored by Allergan. Primary endpoints: Area under the plasma concentration versus time curve from time 0 to time t, Maximum plasma drug concentration and 5 more. Started Dec 2015; status: completed.
02
Drugs
ulipristal
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT02634437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02634437.